Home/Filings/4/0001140361-24-035394
4//SEC Filing

Backus William A. 4

Accession 0001140361-24-035394

CIK 0000009326other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 6:09 PM ET

Size

12.2 KB

Accession

0001140361-24-035394

Insider Transaction Report

Form 4
Period: 2024-07-30
Backus William A.
CAO and Assistant Treasurer
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-07-303,9000 total
    Exercise: $84.09Exp: 2029-02-13Common Stock (3,900 underlying)
  • Sale

    Common Stock

    2024-07-30$180.47/sh330$59,5544,988 total
  • Exercise/Conversion

    Common Stock

    2024-07-30$84.09/sh+3,900$327,9518,888 total
  • Sale

    Common Stock

    2024-07-30$179.25/sh3,570$639,9125,318 total
  • Sale

    Common Stock

    2024-07-30$177.10/sh904$160,094132 total(indirect: By 401(k))
Footnotes (6)
  • [F1]Exercise of fully vested non-qualified stock options.
  • [F2]This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F3]This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F4]Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.
  • [F5]Reflects shares previously acquired under the Balchem Corporation 401(k) plan.
  • [F6]Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001530884

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 6:09 PM ET
Size
12.2 KB